TIMP2 and cancer: Our results demonstrate that inhibition of MMP-9 by the endogenous MMP inhibitor N-TIMP2 and its engineered variant REY effectively suppresses cancer cell proliferation, invasion, and spheroid spread in U251 GB cells.